-+ 0.00%
-+ 0.00%
-+ 0.00%

BRAINSTORM RECEIVES FDA CLEARANCE TO INITIATE PHASE 3B TRIAL OF NUROWN® FOR ALS

Reuters·05/19/2025 11:00:09

Please log in to view news